George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.
Producer: Doni Holloway.

Kevin Warsh Considers Fewer Fed Meetings; Anthropic AI Models Hack Three Organizations
40:03

Aon Keeps Margin Edge as Industry Tailwinds Fade
11:01

Amazon Reports Fifth Straight Quarter of Cloud Sales Growth & Apple Sales Slow Down
45:10